MARKET

NVO

NVO

Novo-Nordisk A/S
NYSE
38.05
+0.09
+0.24%
Opening 10:57 03/16 EDT
OPEN
37.97
PREV CLOSE
37.96
HIGH
38.25
LOW
37.79
VOLUME
3.41M
TURNOVER
--
52 WEEK HIGH
80.53
52 WEEK LOW
35.85
MARKET CAP
168.91B
P/E (TTM)
10.52
1D
5D
1M
3M
1Y
5Y
1D
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks
The Motley Fool · 1h ago
BUZZ-Structure rises after obesity pill shows up to 16.3% weight loss in study
Reuters · 3h ago
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
Benzinga · 3h ago
Weekly Report: what happened at NVO last week (0309-0313)?
Weekly Report · 5h ago
PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
Seeking Alpha · 11h ago
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and CVS Health in focus
Seeking Alpha · 1d ago
Novo Nordisk Telehealth Deal Weighs On Weak Share Price And Valuation
Simply Wall St · 1d ago
Hims & Hers posts best weekly gain after Novo deal
Seeking Alpha · 1d ago
More
About NVO
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Webull offers Novo Nordisk A/S (ADR) stock information, including NYSE: NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVO stock methods without spending real money on the virtual paper trading platform.